Cargando…
Chinese Proprietary Medicine Xianling Gubao Capsule for Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
OBJECTIVE: To assess the benefit and harm of Chinese medicine Xianling Gubao (XLGB) capsule compared to conventional medication or placebo to inform clinical practice. METHODS: We included randomized controlled trials (RCTs) with Jadad score ≥3 of XLGB capsule compared to pharmaceutical medication,...
Autores principales: | Cheng, Bai-Ru, Wu, Rou-Yan, Gao, Qin-Yang, Jiang, Kai-Xin, Li, Shuang-Sang, Qi, Shi-Hao, Yuan, Ming-Yi, Liu, Jian-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022208/ https://www.ncbi.nlm.nih.gov/pubmed/35464071 http://dx.doi.org/10.3389/fendo.2022.870277 |
Ejemplares similares
-
Comparative Efficacy of Xianling Gubao Capsules in Improving Bone Mineral Density in Postmenopausal Osteoporosis: A Network Meta-Analysis
por: Luo, Ming-hui, et al.
Publicado: (2022) -
Xianling Gubao Capsule Prevents Cadmium-Induced Kidney Injury
por: Huang, Jian, et al.
Publicado: (2021) -
Chinese herbal medicine Xianling Gubao capsule for knee osteoarthritis: A protocol for systematic review and meta-analysis
por: Liu, Wang, et al.
Publicado: (2022) -
Efficacy and safety of Xianling Gubao capsule in treating postmenopausal osteoporosis: A protocol for systematic review and meta-analysis
por: Lou, Fanglian, et al.
Publicado: (2021) -
Screening for Susceptibility-Related Factors and Biomarkers of Xianling Gubao Capsule-Induced Liver Injury
por: Li, Chun-yu, et al.
Publicado: (2020)